concept

CASPASE

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about CASPASE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

809Connections

3Hypotheses

0Analyses

50Outgoing

50Incoming

0Experiments

0Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	CASPASE

Pathway Diagram

graph TD
    CASPASE["CASPASE"]
    style CASPASE fill:#1a237e,stroke:#4fc3f7,stroke-width:3px
    CASPASE -->|"activates"| PANoptosis["PANoptosis"]
    CASPASE -->|"cleaves"| GSDME([GSDME])
    CASPASE -->|"activates"| neurodegeneration["neurodegeneration"]
    CASPASE -->|"activates"| IL1B([IL1B])
    CASPASE -->|"regulates"| Fibrosis["Fibrosis"]
    CASPASE -->|"interacts"| Cancer["Cancer"]
    CASPASE -->|"interacts"| Als["Als"]
    CASPASE -.->|"inhibits"| Aging["Aging"]
    RIPK1([RIPK1]) -->|"interacts"| CASPASE
    PPARG([PPARG]) -->|"interacts"| CASPASE
    WNT([WNT]) -->|"regulates"| CASPASE
    TFEB([TFEB]) -->|"interacts"| CASPASE
    CFTR([CFTR]) -->|"regulates"| CASPASE
    RICTOR([RICTOR]) -->|"interacts"| CASPASE
    ROS([ROS]) -->|"regulates"| CASPASE
    GRB2([GRB2]) -->|"interacts"| CASPASE
    HSP70([HSP70]) -->|"interacts"| CASPASE
    STAT3([STAT3]) -->|"interacts"| CASPASE

Outgoing (207)

Target	Relation	Type	Str
PANoptosis	activates	process	0.92
neurodegeneration	activates	process	0.70
Als	expressed_in	disease	0.60
Lymphoma	expressed_in	disease	0.60
Pyroptosis	inhibits	disease	0.60
Pyroptosis	degrades	disease	0.60
Dementia	inhibits	disease	0.60
Als	degrades	disease	0.60
Ferroptosis	inhibits	disease	0.60
Anxiety	inhibits	disease	0.60
Pyroptosis	causes	disease	0.60
Vascular Dementia	therapeutic_target	disease	0.60
Alzheimer	associated_with	disease	0.60
Depression	activates	disease	0.60
Neuroinflammation	inhibits	disease	0.60
Necroptosis	inhibits	disease	0.60
Fibrosis	inhibits	disease	0.60
Fibrosis	regulates	disease	0.60
Cardiomyopathy	inhibits	disease	0.60
Diabetes	inhibits	disease	0.60
Aging	inhibits	disease	0.60
Lymphoma	associated_with	disease	0.60
Cancer	inhibits	disease	0.60
Als	inhibits	disease	0.60
Cancer	expressed_in	disease	0.60
Neurodegeneration	associated_with	disease	0.60
Multiple Sclerosis	regulates	disease	0.60
Amyotrophic Lateral Sclerosis	regulates	disease	0.60
Parkinson	regulates	disease	0.60
Spinal Cord Injury	regulates	disease	0.60
Huntington	regulates	disease	0.60
Diabetes	therapeutic_target	disease	0.60
Aging	therapeutic_target	disease	0.60
Retinopathy	therapeutic_target	disease	0.60
Obesity	regulates	disease	0.60
Diabetes	regulates	disease	0.60
Neurodegeneration	activates	disease	0.60
Als	associated_with	disease	0.60
Neuroinflammation	associated_with	disease	0.60
Hypertension	inhibits	disease	0.60
Fibrosis	activates	disease	0.60
Pyroptosis	regulates	disease	0.60
Necroptosis	regulates	disease	0.60
Aging	encodes	disease	0.60
Multiple Sclerosis	activates	disease	0.60
Traumatic Brain Injury	inhibits	disease	0.60
Epilepsy	therapeutic_target	disease	0.60
Pyroptosis	biomarker_for	disease	0.60
Huntington	activates	disease	0.60
Ferroptosis	biomarker_for	disease	0.60

Incoming (602)

Source	Relation	Type	Str
ASC	inhibits	gene	0.60
STROKE	therapeutic_target	gene	0.60
DEMENTIA	therapeutic_target	gene	0.60
IL-4	therapeutic_target	gene	0.60
ALS	therapeutic_target	gene	0.60
PARKINSON	therapeutic_target	gene	0.60
IL-1	therapeutic_target	gene	0.60
AMYLOID-BETA	associated_with	gene	0.60
APP	associated_with	gene	0.60
MAPK1	activates	gene	0.60
IL1B	activates	gene	0.60
NLRP1	activates	gene	0.60
TLR2	expressed_in	gene	0.60
GSK3B	activates	gene	0.60
LRP1	activates	gene	0.60
PYCARD	expressed_in	gene	0.60
BCL2	expressed_in	gene	0.60
MAPK14	activates	gene	0.60
BAX	expressed_in	gene	0.60
RAGE	expressed_in	gene	0.60
DRD2	activates	gene	0.60
MITOCHONDRIA	degrades	gene	0.60
TAU	degrades	gene	0.60
DYNEIN	activates	gene	0.60
GFP	expressed_in	gene	0.60
ATP	expressed_in	gene	0.60
OPA1	expressed_in	gene	0.60
SYNAPSE	expressed_in	gene	0.60
MICROTUBULES	causes	gene	0.60
PRESENILIN	activates	gene	0.60
HES1	activates	gene	0.60
NOTCH	activates	gene	0.60
PSEN1	activates	gene	0.60
C-JUN	activates	gene	0.60
EPILEPSY	therapeutic_target	gene	0.60
GPX4	biomarker_for	gene	0.60
BDNF	biomarker_for	gene	0.60
HUNTINGTON	activates	gene	0.60
GFAP	biomarker_for	gene	0.60
FERROPTOSIS	biomarker_for	gene	0.60
GASDERMIN	biomarker_for	gene	0.60
NLRP3	biomarker_for	gene	0.60
GSH	biomarker_for	gene	0.60
PYROPTOSIS	biomarker_for	gene	0.60
PARKINSON	protects_against	gene	0.60
RIP3	protects_against	gene	0.60
FOXO3	inhibits	gene	0.60
EXOSOMES	inhibits	gene	0.60
IL-18	inhibits	gene	0.60
ALZHEIMER	therapeutic_target	gene	0.60

Targeting Hypotheses (3)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Caspase-2/3-mediated D421 truncation generates disease-speci	0.455	neurodegeneration	Which specific post-translational modifi
NLRP3 Inflammasome Suppression via Selective Caspase-1 Inhib	0.105	neurodegeneration	Neuroinflammation Biomarker Panel for Ea
Caspase-3 Cleavage of Tau Creates PS-Targeting Specificity	0.000	-	Does tau aggregation specifically cause

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning CASPASE in their description or question text

No additional research found